You are here: Industry Insights > china

News List

Over 1.21b in China fully vaccinated against COVID-19 NMPA/Xinhua
January 11, 2022
Over 1.21 billion people in China have been fully vaccinated against COVID-19, a Chinese health official said at a press conference on Jan 8.
China rushes to develop an mRNA vaccine as doubts grow over local jabs FirstWordPharma
January 07, 2022
China's race to develop its own mRNA vaccine against COVID-19 has gained greater urgency as Beijing struggles to rein in an outbreak of the Omicron coronavirus variant that is threatening its "zero-Covid" policy, reported the Financial Times.
Inovio to commence Covid-19 vaccine prime-boost trials in China pharmaceutical-technology
August 11, 2021
Inovio has obtained regulatory approval from China’s Center for Drug Evaluation of the National Medical Products Administration to conduct two clinical trials of heterologous prime-boosting with its Covid-19 vaccine candidate, INO-4800.
China and India Combat Coronavirus Pandemic Together: Online Ceremony Held for the Handover of Medical Supplies to Aid India prnasia
June 21, 2021
On 11 June 2021, an online ceremony was held for the handover of anti-pandemic supplies to aid India. Medical supplies to India included 135 oxygen concentrators, 5 ventilators and 3,300 KN95 masks.
Chinese patent reforms to bolster pharma innovation europeanpharmaceuticalreview
June 18, 2021
Market research suggests the new drug patent reforms in China, in addition to other regulatory changes, will incentivise innovative pharma research.
Recent patent reforms will bolster innovative pharma research in China: GlobalData expresspharma
June 17, 2021
The highlights of the latest reforms are the drug patent linkage system, introduction of patent term extension for drugs and the patent term compensation system.
Crystec Launches New R&D Center in China contractpharma
April 06, 2021
New site in Haimen, Jiangsu province has been established following an invitation to participate in the Yangtze Delta Advanced Drug Development platform.
China continues to lead high value oncology deals in APAC: GlobalData expresspharma
March 15, 2021
High-value deals have dominated the Asia-Pacific (APAC) pharma strategic partnership landscape in 2020. Within the region, China is well ahead of other countries, particularly in the field of oncology, reveals GlobalData.
Vetter Establishes Office in China contractpharma
March 09, 2021
Vetter has opened a new business office in Shanghai, China, its fourth in the Asia Pacific (APAC) region, to help increase Vetter’s presence in China.
China approves clinical trials for 16 indigenous COVID-19 vaccines expresspharma
February 22, 2021
China has already given conditional approval to two inactivated COVID-19 vaccines made by state-owned developers -- Sinopharm and Sinovac Biotech.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page